Alvaro Teijeira

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

A Lightweight, 3D-Printable, Low-Cost, "One-Click" Dorsal Skin Window for High-Quality Long-Term Multimodal Subcutaneous Tumor Imaging.

A Lightweight, 3D-Printable, Low-Cost, "One-Click" Dorsal Skin Window for High-Quality Long-Term Multimodal Subcutaneous Tumor Imaging.

Journal: Advanced healthcare materials

Published: March 09, 2026

CD137 agonists in mice suppress germinal center responses by increasing the immunosuppressive activity of follicular regulatory T-cells.

CD137 agonists in mice suppress germinal center responses by increasing the immunosuppressive activity of follicular regulatory T-cells.

Journal: The EMBO journal

Published: January 04, 2026

Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

Journal: Cancer research

Published: December 22, 2025

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

Journal: The Journal of experimental medicine

Published: October 08, 2025

Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer.

Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer.

Journal: The Journal of clinical investigation

Published: October 07, 2025

Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Journal: Nature

Published: October 01, 2025

Antigen-presenting mast cells are new players in breast cancer immunotherapy.

Antigen-presenting mast cells are new players in breast cancer immunotherapy.

Journal: Nature medicine

Published: June 25, 2025

Cross-priming in cancer immunology and immunotherapy.

Cross-priming in cancer immunology and immunotherapy.

Journal: Nature reviews. Cancer

Published: December 03, 2024

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

Journal: Journal for immunotherapy of cancer

Published: November 01, 2024

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.

Journal: Oncoimmunology

Published: July 11, 2024

Spatially resolved tissue imaging to analyze the tumor immune microenvironment: beyond cell-type densities.

Spatially resolved tissue imaging to analyze the tumor immune microenvironment: beyond cell-type densities.

Journal: Journal for immunotherapy of cancer

Published: May 13, 2024

DSTYK Inhibition Sensitizes NSCLC to Taxane-Based Chemotherapy.

DSTYK Inhibition Sensitizes NSCLC to Taxane-Based Chemotherapy.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 03, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026